期刊文献+

血府逐瘀汤联合酚磺乙胺治疗肋骨骨折伴血胸临床研究 被引量:1

Clinical Study on Xuefu Zhuyu Tang Combined with Etamsylate for Rib Fracture Complicated with Hemothorax
下载PDF
导出
摘要 目的:观察血府逐瘀汤联合酚磺乙胺治疗肋骨骨折伴血胸的临床疗效及其对患者疼痛、生活质量的影响。方法:选取108例肋骨骨折伴血胸患者,根据治疗方法的不同分为治疗组和对照组各54例。治疗组给予血府逐瘀汤联合酚磺乙胺治疗,对照组给予酚磺乙胺治疗。观察比较2组临床疗效、生活质量、疼痛视觉模拟评分法(VAS)评分、症状消失时间及凝血功能指标[凝血酶原时间(PT)、活化部分凝血活酶时间(APTT)、凝血酶时间(TT)、纤维蛋白原(Fib)、D-二聚体(D-D)]变化。结果:治疗组总有效率为94.44%,对照组为77.78%,2组比较,差异有统计学意义(P<0.05)。治疗后,2组生存质量评分均较治疗前提高(P<0.05),疼痛VAS评分均较治疗前降低(P<0.05);且治疗组生存质量评分高于对照组(P<0.05),VAS评分低于对照组(P<0.05)。治疗后,2组PT、APTT、TT水平均较治疗前升高(P<0.05),Fib、D-D水平均较治疗前降低(P<0.05);且治疗组上述各项指标改善较对照组更显著(P<0.05)。治疗后,治疗组疼痛消失时间、血胸消失时间均短于对照组(P<0.05)。结论:血府逐瘀汤联合酚磺乙胺治疗肋骨骨折伴血胸患者疗效确切,可有效减轻疼痛,提高生活质量,有利于改善凝血功能,加速病情康复。 Objective:To observe the clinical effect of the therapy of Xuefu Zhuyu tang combined with etamsylate on rib fracture complicated with hemothorax and its effect on patients’ pain and quality of life.Methods:A total of 108 patients with rib fracture complicated with hemothorax were selected and divided into the treatment group and the control group according to different treatment methods,with 54 cases in each group.The treatment group was treated with the therapy of Xuefu Zhuyu tang combined with etamsylate,and the control group was simply treated with etamsylate.The clinical effects,and the changes in quality of life,scores of Visual Analogue Scale(VAS) of pain,disappearance time of symptoms and levels of coagulation function indexes,including prothrombin time(PT),activated partial thrombin time(APTT),thrombin time(TT),fibrinogen(Fib) and D-dimer(D-D),were observed and compared between the two groups.Results:The total effective rate was 94.44% in the treatment group and 77.78% in the control group,the difference being significant(P<0.05).After treatment,the scores of quality of life in both groups were increased when compared with those before treatment(P<0.05),and the VAS scores of pain were decreased(P<0.05);the score of quality of life in the treatment group was higher than that in the control group(P<0.05),and the VAS score was lower(P<0.05).After treatment,the levels of PT,APTT and TT in the two groups were increased when compared with those before treatment(P<0.05),and the levels of Fib and D-D were decreased(P<0.05);the improvement of the above indexes in the treatment group was more significant than that in the control group(P<0.05).After treatment,the disappearance time of pain and hemothorax in the treatment group was shorter than that in the control group(P<0.05).Conclusion:The therapy of Xuefu Zhuyu tang combined with etamsylate has a definite curative effect on patients with rib fracture complicated with hemothorax,which can relieve pain,improve the quality of life,enhance the coagulation function and promote recovery.
作者 张怀忠 鄢琛尹 吴旭辉 ZHANG Huaizhong;YAN Chenyin;WU Xuhui
出处 《新中医》 CAS 2022年第16期44-47,共4页 New Chinese Medicine
关键词 肋骨骨折伴血胸 血府逐瘀汤 酚磺乙胺 凝血功能 视觉模拟评分法 生活质量 Rib fracture complicated with hemothorax Xuefu Zhuyu tang Etamsylate Coagulation function Visual Analogue Scale Quality of life
  • 相关文献

参考文献10

二级参考文献131

  • 1万新焕,王瑜亮,周长征,郭浩,马山,王立柱.丹参化学成分及其药理作用研究进展[J].中草药,2020,51(3):788-798. 被引量:396
  • 2顾剑峰,蒋治平,张健.纯钛肋骨爪形接骨板内固定治疗多发肋骨骨折疗效观察[J].山东医药,2013,53(30):43-44. 被引量:21
  • 3许海燕,葛晓松,张晓辉,成传德,张雪堂.中西医结合治疗多发性肋骨骨折并气血胸[J].中医正骨,2006,18(2):57-58. 被引量:14
  • 4Ware JE Jr, Snow KK, Kosinski M, et al.SF-36 health survey manual and interpretation guide.Boston: New England Medical Center the Health Institute,1993.1-12.
  • 5Perneger TV, Leplege A, Etter JF,et al.Validation of a French-language version of the MOS 36-Item Short Form Health Survey(SF-36) in young healthy adults.J Clin Epidemiol, 1995,48:1051-1060.
  • 6Guillemin F, Bombardier C, Beaton D.Cross-cultural adaptation of health-related quality of life measures: literature review and proposed guidelines.J Clin Epidemiol, 1993,46:1417-1432.
  • 7Gandek B, Ware JE Jr.Methods for validating and norming translations of health status questionnaires: the IQOLA Project approach.International Quality of Life Assessment.J Clin Epidemiol, 1998,51:953-959.
  • 8顾杏元,金丕焕.直线回归与相关.见: 金丕焕,主编.医用统计方法.上海:上海医科大学出版社,1993.115-119.
  • 9Lam CL, Gandek B, Ren XS, et al.Tests of scaling assumptions and construct validity of the Chinese(HK) version of the SF-36 Health Survey.J Clin Epidemiol, 1998,51:1139-1147.
  • 10Ren XS, Amick B 3rd, Zhou L, et al.Translation and psychometric evaluation of a Chinese version of the SF-36 Health Survey in the United States.J Clin Epidemiol, 1998,51:1129-1138.

共引文献2272

同被引文献22

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部